Development of Market Access Strategy

Aston Health has sufficient resources and experience to offer its clients the turnkey solutions for market access and pricing assessments:

  • Conducting HTA analysis using own resources and in collaboration with the leading pharmacoeconomic institutions in this country
  • Generating research information from Patient Registers in more than 20 disease areas
  • Identifying regional potential in reimbursement segment: cross-analysis of sales data  (based on public tenders) and prescribing volumes (based on registry data) – Aston 360
  • Pricing studies
  • Developing Market Access Strategies on federal and regional levels
  • Tracking changes in the Russian healthcare system – PharmCompass Россия and PharmCompass Регионы

In recent years, the Russian pharmaceutical market has been undergoing significant changes, especially with respect to public regulation and funding, which had a significant impact on market entry strategies.

Market Access and HTA are playing an increasing role in the commercial success of marketed drugs, medical devices and equipment in the region-specific environment.

This requires industry players to focus on obtaining proper and timely insights on regulatory and funding changes at federal and regional level.

Aleksandr Ivanov

Aleksandr Ivanov

Head of Strategic Consulting Department